XML 37 R26.htm IDEA: XBRL DOCUMENT v3.26.1
STOCK BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of stock-based compensation expense
                 
  

Three Months Ended

June 30,

  Six Months Ended
June 30,
   2026  2025  2026  2025
Research and development  $631   $536   $1,165   $995 
General and administrative   1,038    740    1,867    1,339 
Selling and marketing   72    2    115    (47)
Total  $1,741   $1,278   $3,147   $2,287 
Schedule of time based stock option activity
                     
  

Number of

Shares

 

Weighted-

Average

Exercise

Prices per Share

 

Weighted-
Average

Remaining

Contractual

Term (In Years)

  Intrinsic
Value
Outstanding at January 1, 2026   2,907   $6.53           
Granted   110   $5.30           
Exercised   (190)  $6.73           
Forfeited   (1)  $9.91           
Expired   (155)  $7.84           
Outstanding at June 30, 2026   2,671   $6.38    4.74   $8,195 
Exercisable at June 30, 2026   2,143   $6.72    3.80   $6,245 
Schedule of restricted stock activity
      
  

Number of

Shares

 

Weighted-Average

Grant Date Fair Value per Share

Outstanding at January 1, 2026   234   $6.90 
Vested   (73)  $7.81 
Forfeited   (7)  $6.49 
Outstanding non-vested shares at June 30, 2026   154   $6.49 
Schedule of restricted stock unit activity
                    
  Time-Based
Units
  Performance-
Based Units
  Total Restricted Stock Units  Weighted-Average Grant Date Fair Value per Share
Outstanding at January 1, 2026   387    221    608   $7.62 
Granted   512    277    789   $6.92 
Vested   (166)       (166)  $6.55 
Forfeited   (47)   (74)   (121)  $7.07 
Outstanding at June 30, 2026   686    424    1,110   $7.35 
Performance Based Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of performance based stock option activity
            
  

Number of

Shares

 

Weighted-

Average

Exercise

Prices per Share

 

Weighted-
Average

Remaining

Contractual

Term (In Years)

  Intrinsic
Value
Outstanding at January 1, 2026      $           
Granted   736   $5.10           
Outstanding at June 30, 2026   736   $5.10    9.70   $2,658 
Exercisable at June 30, 2026      $       $